These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1900124

  • 1. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
    Cervellino JC, Araujo CE, Pirisi C, Francia A, Cerruti R.
    Oncology; 1991; 48(2):89-92. PubMed ID: 1900124
    [Abstract] [Full Text] [Related]

  • 2. Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
    Cervellino JC, Araujo CE, Pirisi C, Sanchez O, Brosto M, Rossi R.
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S1-3. PubMed ID: 2112052
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK.
    Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: a study of the Grupo de Estudio y Tratamiento Latino-Americano del Cancer.
    Araujo CE, Cervellino JC, Pirisi C, Pannunzio O, Callegari J.
    J Surg Oncol; 1991 Mar 15; 46(3):198-202. PubMed ID: 1901372
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck.
    Pai VR, Parikh DM, Mazumdar AT, Rao RS.
    Oncology; 1993 Mar 15; 50(2):86-91. PubMed ID: 8451041
    [Abstract] [Full Text] [Related]

  • 7. Ifosfamide in advanced epidermoid head and neck cancer.
    Martín M, Diaz-Rubio E, González Larriba JL, Casado A, Sastre J, López-Vega JM, Almenarez J, Dominguez S.
    Cancer Chemother Pharmacol; 1993 Mar 15; 31(4):340-2. PubMed ID: 8422700
    [Abstract] [Full Text] [Related]

  • 8. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
    Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Dunnington JS, Hong WK.
    Am J Clin Oncol; 1996 Aug 15; 19(4):379-82. PubMed ID: 8677909
    [Abstract] [Full Text] [Related]

  • 9. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Recchia F, Saggio G, Cesta A, Amiconi G, di Blasio A, Candeloro G, Valeriani M, Tombolini V, Rea S.
    Anticancer Res; 2006 Aug 15; 26(3B):2317-24. PubMed ID: 16821609
    [Abstract] [Full Text] [Related]

  • 10. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
    Specenier PM, Van Den Brande J, Schrijvers D, Huizing MT, Altintas S, Dyck J, Van Den Weyngaert D, Van Laer C, Vermorken JB.
    Anticancer Res; 2009 Dec 15; 29(12):5137-42. PubMed ID: 20044628
    [Abstract] [Full Text] [Related]

  • 11. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Thurnher D, Kornfehl J, Burian M, Gedlicka C, Selzer E, Quint C, Neuchrist C, Kornek GV.
    Anticancer Drugs; 2001 Mar 15; 12(3):205-8. PubMed ID: 11290867
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.
    Manegold C, Drings P, Pawinski A, Lentz MA, van Glabbeke M, van Zandwijk N, Bachmann P, Schnaars Y, Skacel Z, Zatloukal P, Dolensky J, Jackevicius A, Petruzelka L, Giaccone G.
    Ann Oncol; 1996 Aug 15; 7(6):637-9. PubMed ID: 8879380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
    Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Ang KK, Clayman GL, Callender DL, Hong WK, Lippman SM.
    J Clin Oncol; 1998 Apr 15; 16(4):1325-30. PubMed ID: 9552033
    [Abstract] [Full Text] [Related]

  • 17. Gynecologic Oncology Group experience with ifosfamide.
    Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.
    Semin Oncol; 1990 Apr 15; 17(2 Suppl 4):6-10. PubMed ID: 2159188
    [Abstract] [Full Text] [Related]

  • 18. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.
    Semin Oncol; 1989 Feb 15; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [Abstract] [Full Text] [Related]

  • 19. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.
    Semin Oncol; 1998 Apr 15; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.